Streetbeat News

Earnings

CGTX

Cognition Therapeutics (NASDAQ:CGTX) reported mixed results from its Phase 2 'SHINE' study for Alzheimer's treatment CT1812. While there were trends of cognitive improvement and functional benefits, the drug did not achieve statistical significance on secondary efficacy endpoints. The stock fell 35.10% to $1.54 following the news.

Portfolio Pulse from Vandana Singh

July 29, 2024 | 3:31 pm

AMC

DIS

AMC Entertainment Holdings Inc (NYSE:AMC) shares are rising after the company reported record-breaking weekend attendance and admissions revenue for 2024. The success was driven by the opening weekend of Walt Disney Co (NYSE:DIS) and Marvel's 'Deadpool & Wolverine,' which set new records for an R-rated film. AMC also saw its highest food and beverage revenue since 2019 and strong merchandise sales.

Portfolio Pulse from Adam Eckert

July 29, 2024 | 3:24 pm

CTRI

Centuri shares are trading lower after the company reported worse-than-expected Q2 earnings and provided lower-than-expected 2024 guidance.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 3:16 pm

BMRC

Bank of Marin shares are trading lower after the company reported worse-than-expected Q2 earnings.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 3:12 pm

COMM

NIPG

OIS

ON

TSLA

ON Semiconductor, Oil States International, CommScope Holding, and other major stocks saw significant gains on Monday. ON Semiconductor reported better-than-expected Q2 results, leading to a 13.7% rise in its stock price. Other notable gainers include NIP Group, Meta Data Limited, and Tesla.

Portfolio Pulse from Avi Kapoor

July 29, 2024 | 3:09 pm

BTCUSD

MCD

TSLA

Bitcoin rises following support from Trump, McDonald's stock declines after missing earnings expectations, and Morgan Stanley reiterates a bullish rating on Tesla.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 3:03 pm

SNOW

Whales have shown unusual options activity for Snowflake (NYSE:SNOW), with a mix of bullish and bearish trades. Analysts have set a consensus target price of $198.33, with individual targets ranging from $165 to $220. The stock is currently trading at $128.96, down by 0.03%, and may be approaching oversold territory.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 3:02 pm

APP

AppLovin (NASDAQ:APP) has received mixed analyst ratings over the past three months, with a majority being bullish. Analysts have raised their price targets, reflecting positive sentiment. The company's financial performance shows strong revenue growth, net margin, ROE, and ROA, but it has a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 3:01 pm

QCOM

The article provides an in-depth analysis of Qualcomm (NASDAQ:QCOM) compared to its competitors in the Semiconductors & Semiconductor Equipment industry. It highlights Qualcomm's financial metrics, market positioning, and growth potential, indicating potential undervaluation based on PE, PB, and PS ratios, strong profitability with high ROE and gross profit, but concerns over low EBITDA and revenue growth.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 3:01 pm

WDAY

The article provides a comprehensive analysis of Workday (NASDAQ:WDAY) in comparison to its major competitors in the software industry. Key financial metrics such as P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth are examined. Workday shows potential undervaluation with low P/E, P/B, and P/S ratios but has lower profitability metrics like ROE, EBITDA, and gross profit. However, it boasts a high revenue growth rate and a favorable debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 3:00 pm